Facebook
X
LinkedIn
Forward
2026 UT Southwestern Liver Disease and Transplant Symposium (RP2604B)
This hybrid educational event offers the flexibility to join either in person or virtually and provides an engaging look at the innovative work happening within the Liver Transplant Program at UT Southwestern Medical Center.
Through a blend of expert insights and real-world case scenarios, this session will highlight how our program is expanding access to lifesaving liver transplantation. The program will also showcase emerging advances, such as machine perfusion technologies that are helping to expand the donor pool and create new opportunities for patients in need.
Participants will explore the latest research and patient cases involving severe acute alcoholic hepatitis (SAAH) and metabolic dysfunction-associated steatotic liver disease (MASLD), learn more about living-donor liver transplantation (LDLT) to better understand optimal referral timing, and gain a forward-looking view of liver transplantation throughout 2026 and beyond.
We look forward to bringing colleagues together for an informative and inspiring discussion about the future of liver transplantation!
Target Audience
- Gastroenterologists and Hepatologists
- Nurse Practitioners
- Physician Assistants
- Hospitalists
- Intensive Care Unit (ICU) Attendings
- Nurses
- Oncology Fellows, Residents, and Medical Students
Learning Objectives
- Evaluate the clinical approach and outcomes for patients with Severe Acute Alcoholic Hepatitis (SAAH), including literature review and real case examples.
- Describe the role and benefits of Living Donor Liver Transplantation (LDLT), including its potential to expand the donor pool, reduce mortality, and the use of machine perfusion technologies.
- Discuss the scope for transplanting patients with hepatocellular carcinoma and other malignancies.
- Review current transplant program protocols, including the careful selection of patients with different types of cancers (hepatocellular carcinoma, cholangiocarcinoma, colorectal cancer with hepatic metastases) who would traditionally not have been eligible for transplant.
- Identify the clinical presentation of Acute on Chronic Liver Failure (ACLF) emphasizing it as a common and severe complication of liver disease, and the need for early diagnosis and timely referral.
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Non-Physician
The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 3.0 AMA PRA Category 1 Credits™.
Available Credit
- 3.00 AMA
- 3.00 Attendance
Your company can support this program:
To participate as an exhibitor, please complete the Intent to Exhibit Form .
Price
Registration Fees
| Early Bird 2/21 – 3/6 | General 03/7 – 4/8 | On-site/Late 4/9 – 4/11 | |
|---|---|---|---|
| Physician (MD/DO) | $25 | $50 | $75 |
| Advance Practice Provider (PA/NP) | $25 | $50 | $75 |
| Nurse | $25 | $50 | $75 |
| Fellows | $25 | $50 | $75 |
| Residents or Medical Students | $0 | $0 | $25 |
| Other Healthcare Professional | $25 | $50 | $75 |
| Industry Representative Attendee (Non-Exhibit) | $75 | $100 | $125 |
Registration
To register:
- Login to your existing account or create an account in EthosCE, online learning management system, by selecting the "Register" link.
- Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
- In the following "checkout" pages you will verify and process your payment.
- After registration is completed, a confirmation will be sent by email.